Expression of the cyclin‐dependent kinase inhibitors p16INK4, p15INK4B and p21Waf1/cip1 in human breast cancer

International Journal of Cancer

Volumn 63, Issue 4, 1995, Pages 584-591

  Musgrove, Elizabeth A ^a   Liuschkis, Richard ^a   Cornish, Ann L ^a   Lee, Christine S L ^a   Setlur, Vittal ^b   Seshadri, Ram ^b   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FEMALE; GENE DELETION; GENE EXPRESSION; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN P16; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028845853     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910630420     Document Type: Article

References (36)

1. Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines
2. Cellular localization and T antigen binding of the retinoblastoma protein
3. Cyclin D1 protein expression and function in human breast cancer
4. Expression and amplification of cyclin genes in human breast cancer
5. Epithelial HBL‐100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information
6. A single nucleotide substitution at codon 21 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53‐inducible gene WAF1/CIP1
7. “Touchdown” PCR to circumvent spurious priming during gene amplification
8. Characterization of chromosomal abnormalities in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes
9. WAF1, a potential mediator of p53 tumor suppression
10. INK4B/MTS2‐related CDK6 inhibitor, correlates with wild‐type pRb function
11. Isolation and characterization of full‐length cDNA clones for human α‐, β‐ and γ‐actin mRNAs: skeletal but not cytoplasmic actins have an amino‐terminal cysteine that is not subsequently removed
12. INK4B is a potential effector of TGF‐β‐induced cell cycle arrest
13. 1 cyclin‐dependent kinases
14. Cyclins and cancer II: cyclin D and CDK inhibitors come of age
15. Cell‐cycle regulators and cancer
16. A cell cycle regulator potentially involved in genesis of many tumour types
17. Inactivation of the retinoblastoma susceptibility gene in human breast cancers
18. Polymorphisms and probable lack of mutation in the WAF1‐CIP1 gene in colorectal cancer
19. Transcriptional repression of the D‐type cyclin‐dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb
20. Growth factor, steroid and steroid antagonist regulation of cyclin gene expression associated with changes in T‐47D human breast cancer cell cycle progression
21. 1 to complete the cell cycle
22. Mutations in the p53 gene occur in diverse human tumor types
23. Deletions of the cyclin‐dependent kinase‐4 inhibitor gene in multiple human cancers
24. INK4 in human cancer
25. INK4/MTS1 tumour suppressor gene product
26. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells
27. Mutations in p53 as potential molecular markers for human breast cancer
28. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer
29. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4
30. Clinical significance of HER‐2/neu oncogene amplification in primary breast cancer
31. Mechanisms of WAF1/Cip1 gene expression in human breast carcinoma: role of p53‐dependent and independent signal transduction pathways
32. Ink4
33. Structural rearrangement of the retinoblastoma gene in human breast carcinoma
34. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium
35. p21 is a universal inhibitor of cyclin kinases
36. ink4) in human breast carcinomas